Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ATNF

180 Life Sciences (ATNF)

180 Life Sciences Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATNF
DateTimeSourceHeadlineSymbolCompany
03/14/20247:30AMGlobeNewswire Inc.180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:ATNF180 Life Sciences Corporation
03/11/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
03/08/20243:49PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
02/29/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
02/28/20245:42AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
02/28/20245:39AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
02/28/20245:37AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
02/28/20245:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
02/26/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
02/26/20246:00AMGlobeNewswire Inc.180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanNASDAQ:ATNF180 Life Sciences Corporation
02/20/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
02/16/20244:10PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
02/16/20244:08PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
02/16/20244:05PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
02/16/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
02/12/20243:15PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
01/31/20244:29PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ATNF180 Life Sciences Corporation
01/29/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
01/17/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
01/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
12/28/20235:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATNF180 Life Sciences Corporation
12/27/20233:15PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATNF180 Life Sciences Corporation
12/26/20233:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
12/21/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
12/20/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
12/18/20233:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATNF180 Life Sciences Corporation
12/15/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
12/14/20233:30PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
12/04/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
12/04/20238:00AMGlobeNewswire Inc.180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesNASDAQ:ATNF180 Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:ATNF